Live Updates S&P 500 Nears Record High Amid Tech Redemption 1:31 pm Stocks have reclaimed pre-DeepSeek levels as the S&P 500 looks to close out January higher. The S&P 500 is on pace for a 3%-plus ...

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more than 20 years.

Shares of Charter Communications, Inc. CHTR +5.52% Get Free Report rose during Friday's session after the company reported ...

Uber and Lyft (NASDAQ: LYFT) shares faced pressure this week following a series of autonomous vehicle (AV) developments, including Tesla’s plans for self-drivin ...

Vertex Pharmaceuticals announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Broadcom’s business relies heavily on their networking products, which are crucial for data transfer in AI systems. If the market for premium AI chips experiences a downturn, amid the rise of DeepSeek ...

Vertex Pharmaceuticals Incorporated will report its fourth quarter and full year 2024 financial results on Monday, February 10, 2025 after the financial markets close. The company will host a ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

Three Motley Fool contributors believe they've identified healthcare stocks in the latter category. Here's why they think Eli Lilly (NYSE: LLY), Intuitive Surgical (NASDAQ: ISRG), and Vertex ...